Advanced Tumor Profiling for Personalized Targeted Anti-cancer Treatments
What
Deep tumor profiling to identify molecular features including gene variants and gene expression to identify patients who may benefit from targeted anti-cancer treatments.
For Whom
Patients who have been advised molecular tumor profiling for selection of targeted anti-cancer treatments.
How
Tumor components including proteins, DNA and RNA are isolated from tumor tissue and blood and used for molecular profiling to identify features associated with response to targeted anti-cancer agents.
Why
CellDx™’s deep tumor profiling provides a detailed insight into tumor molecular dynamics which can inform selection of safe and more efficacious treatment regimens.
Advantages
Includes assessment of all molecular biomarkers indicated in the NCCN guidelines.
Evaluates additional clinically relevant biomarkers.
Guides treatment selection in labeled as well as label-agnostic settings.
Explore
A Simple Blood Test To Detect Cancer Early,
So That It Could Be Cured.
Accreditations
Contact Us
United Kingdom
95488 Eckersdorf,
Germany
Maharashtra – 422010.
India